Share ownership Merck & Co., Inc.

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:20 2025-12-05 pm EST			After hours 06:00:11 pm
99.72 ^USD	-1.16%		99.79	+0.07%

Dec. 05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE
Dec. 05	Global markets live: Netflix, Visa, Airbus, Ferrovial, Leonardo…

Share class: Merck & Co., Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,577,103,522	2,528,032,964 ( 70.67 %)	1,045,073,377 ( 29.22 %)	70.67 %

Major shareholders: Merck & Co., Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 10.09 %	252,136,910	10.09 %	21 679 M $
BlackRock Advisors LLC 6.48 %	161,866,866	6.48 %	13 917 M $
STATE STREET CORPORATION 4.731 %	118,180,178	4.731 %	10 161 M $
Wellington Trust Co., NA 3.014 %	75,279,104	3.014 %	6 472 M $
Geode Capital Management LLC 2.394 %	59,798,874	2.394 %	5 142 M $
Charles Schwab Investment Management, Inc. 2.15 %	53,699,460	2.15 %	4 617 M $
BlackRock Life Ltd. 1.877 %	46,874,297	1.877 %	4 030 M $
Eaton Vance Management 1.785 %	44,586,535	1.785 %	3 834 M $
Norges Bank (13F) 1.446 %	36,111,289	1.446 %	3 105 M $
JPMorgan Investment Management, Inc. 1.414 %	35,325,168	1.414 %	3 037 M $
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.001112 %	222,130	0.001112 %	2 M $
Safra Asset CTVM SA (Investment Management) 0.000237 %	47,400	0.000237 %	516 140 $
XP Allocation Asset Management Ltda. 0.000026 %	5,130	0.000026 %	55 861 $
E2M Investimentos Ltda. 0.000006 %	1,100	0.000006 %	11 978 $

Breakdown by shareholder type

Institutional	63.34%
Other	7.94%
State Street Corp.	4.73%
Swedbank AB	0.33%
Sumitomo Mitsui Trust Group, Inc.	0.29%
Schweizerische Nationalbank	0.29%
Governments	0.16%
SEI Investments Co.	0.1%
ABN AMRO Bank NV	0.08%
Danske Bank A/S	0.08%
Manulife Financial Corp.	0.07%
Skandinaviska Enskilda Banken AB	0.07%
The Bank of Nova Scotia	0.06%
Individuals	0.05%
Regions Financial Corp.	0.05%
Münchener Rückversicherungs-Gesellschaft AG	0.04%
ING Groep NV	0.03%
First Financial Bankshares, Inc.	0.03%
Old Republic International Corp.	0.03%
Rathbones Group Plc	0.02%
Peapack-Gladstone Financial Corp.	0.02%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Fifth Third Bancorp	0.02%
Commerzbank AG	0.01%
Hancock Whitney Corp.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Fairfax Financial Holdings Ltd.	0.01%
Ally Financial, Inc.	0.01%
Hennessy Advisors, Inc.	0.01%
Unknown	22.07%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	58.49%
United Kingdom	7.35%
Canada	2.51%
Norway	1.61%
France	1.07%
Sweden	1.04%
Switzerland	0.81%
Japan	0.78%
Australia	0.77%
Denmark	0.58%
Germany	0.49%
Luxembourg	0.39%
Netherlands	0.39%
Hong Kong	0.35%
South Korea	0.3%
Ireland	0.22%
Belgium	0.15%
Italy	0.12%
Spain	0.09%
Finland	0.09%
New Zealand	0.06%
Singapore	0.05%
Austria	0.05%
Individuals	0.05%
Czech Republic	0.03%
Liechtenstein	0.02%
Saudi Arabia	0.01%
Brazil	0.01%
South Africa	0.01%
Puerto Rico	0.01%
Slovenia	0.01%
China	0.01%
Mexico	0.01%

Based on 1000 largest holdings

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (20%); - sale of animal health products (9.2%); - other (1.4%). Net sales are distributed geographically as follows: the United States (50.3%), Europe/Middle East/Africa (21.8%), Latin America (5.4%), China (8.6%), Japan (5.1%), Asia/Pacific (4.8%) and other (4%).

Employees

74,000

Sector

Pharmaceuticals

Calendar

Dec. 14 - Ex-dividend day

More about the company